Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 3 24-3, 2001, Pages

  Lukacs, Nicholas W ^a   Glovsky, M Michael ^b   Ward, Peter A ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

Histamine; Lung; Tumor necrosis factor

Indexed keywords

COBROTOXIN; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; HISTAMINE; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHITIS; BRONCHUS HYPERREACTIVITY; COMPLEMENT ACTIVATION; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; IMMUNE COMPLEX DEPOSITION; IMMUNE RESPONSE; LUNG INJURY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034997192     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.3.l512     Document Type: Article

References (67)

1. Alpert SE, Pennington JE, and Colten HR. Synthesis of complement by guinea pig bronchoalveolar macrophages. Effect of acute and chronic infection with Pseudomonas aeruginosa. Am Rev Respir Dis 129: 66-71, 1984.
2. Argenbright LW and Barton RW. Interactions of leukocyte integrins with intercellular adhesion molecule-1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited. J Clin Invest 89: 259-272, 1992.
3. Ballow M and Cochrane CG. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol 103: 944-952, 1969.
4. Behera AK, Kumar M, Matsuse H, Lockey RF, and Mohapatra SS. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 251: 704-709, 1998.
5. Bertrand C and Geppetti P. Tachykinin and kinin receptor antagonists: therapeutic perspectives in allergic airway disease. Trends Pharmacol Sci 17: 255-259, 1996.
6. Burdick MD, Kunkel SL, Lincoln PM, Wilke CA, and Strieter RM. Specific ELISAs for the detection of human macrophage inflammatory protein-1 alpha and beta. Immunol Invest 22: 441-449, 1993.
7. Busse WW. Leukotrienes and inflammation. Am J Respir Crit Care Med 157: S210-S213, 1998.
8. Campbell EM, Charo IF, Kunkel SL, Strieter RM, Boring L, Gosling J, and Lukacs NW. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/-mice: the role of mast cells. J Immunol 163: 2160-2167, 1999.
9. Campbell E, Hogaboam C, Lincoln P, and Lukacs NW. Stem cell factor-induced airway hyperreactivity in allergic and normal mice. Am J Pathol 154: 1259-1265, 1999.
10. Campbell E, Kunkel SL, Strieter RM, and Lukacs NW. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J Immunol 161: 7047-7053, 1998.
11. Campbell E, Kunkel SL, Strieter RM, and Lukacs NW. Differential roles of IL-18 in allergic airway disease: induction of eotaxin by resident cell populations exacerbates eosinophil accumulation. J Immunol 164: 1096-1102, 2000.
12. Cochrane CG. The role of immune complexes and complement in tissue injury. J Allergy 42: 113-129, 1968.
13. Cochrane CG, Muller-Eberhard HJ, and Aikin BS. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol 105: 55-69, 1970.
14. Cole FS, Matthews WJ Jr, Marino JT, Gash DJ, and Colten HR. Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages. J Immunol 125: 1120-1124, 1980.
15. Curran AD. The role of nitric oxide in the development of asthma. Int Arch Allergy Immunol 111: 1-4, 1996.
16. Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, Schmal H, Friedl HP, and Ward PA. Protective effects of C5a blockade in sepsis. Nat Med 5: 788-792, 1999.
17. Dehring DJ, Steinberg SM, Wismar BL, Lowery BD, Carey LC, and Cloutier CT. Complement depletion in a porcine model of septic acute respiratory disease. J Trauma 27: 615-625, 1987.
18. Drazen JM. Leukotrienes as mediators of airway obstruction. Am J Respir Crit Care Med 158: S193-S200, 1998.
19. FitzGerald JM and Macklem P. Fatal asthma. Annu Rev Med 47: 161-168, 1996.
20. Ford-Hutchinson AW. Activation of leukotriene production in granulocytes: effects on cell activation. Immunol Ser 57: 87-106, 1992.
21. Gerard C and Gerard NP. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol 12: 775-808, 1994.
22. Glovsky MM, Hugli TE, Ishizaka T, Lichtenstein LM, and Erickson BW. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. J Clin Invest 64: 804-811, 1979.
23. Hartman CT Jr and Glovsky MM. Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release. Int Arch Allergy Appl Immunol 66: 274-281, 1981.
24. Hill LD, Sun L, Leuschen MP, and Zach TL. C3 synthesis by A549 alveolar epithelial cells is increased by interferon-γ and dexamethasone. Immunology 79: 236-240, 1993.
25. Hook WA, Siraganian RP, and Wahl SM. Complement-induced histamine release from human basophils. I. Generation of activity in human serum. J Immunol 114: 1185-1190, 1975.
26. Inman RD and Day NK. Immunologic and clinical aspects of immune complex disease. Am J Med 70: 1097-1106, 1981.
27. Johnson KJ and Ward PA. Role of oxygen metabolites in immune complex injury of lung. J Immunol 126: 2365-2369, 1981.
28. Jose PJ, Forrest MJ, and Williams TJ. Human C5a des Arg increases vascular permeability. J Immunol 127: 2376-2380, 1981.
29. Kay AB. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin Exp Immunol 1: 723-737, 1970.
30. Kilgore KS, Shen JP, Miller BF, Ward PA, and Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 155: 1434-1441, 1995.
31. Kings M, Nydegger UE, and de Weck AL. Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway. Immunology 51: 123-131, 1984.
32. Kraneveld AD, Folkerts G, Van Oosterhout AJ, and Nijkamp FP. Airway hyperresponsiveness: first eosinophils and then neuropeptides. Int J Immunopharmacol 19: 517-527, 1997.
33. Langlois PF and Gawryl MS. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. Am Rev Respir Dis 138: 368-375, 1988.
34. Larsen GL, Presley DM, Graves JP, and Giclas PC. The effect of intravascular complement activation and brief episodes of hypoxia on protein in bronchoalveolar lavage fluid in C5 sufficient and deficient mice. Pediatr Pulmonol 11: 302-309, 1991.
35. Lozada C, Levin RI, Huie M, Hirschhorn R, Naime D, Whitlow M, Recht PA, Golden B, and Cronstein BN. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci USA 92: 8378-8382, 1995.
36. Lucchesi BR. Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke 24, Suppl 12: 141-147, 1993.
37. Lukacs NW and Ward PA. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. Adv Immunol 62: 257-304, 1996.
38. Manian P. Genetics of asthma: a review. Chest 112: 1397-1408, 1997.
39. McFadden ER Jr. Exercise-induced airway obstruction. Clin Chest Med 16: 671-682, 1995.
40. Meza C and Gershwin ME. Why is asthma becoming more of a problem? Curr Opin Pulm Med 3: 6-9, 1997.
41. Mulligan MS, Johnson KJ, Todd RF III, Issekutz TB, Miyasaka M, Tamatani T, Smith CW, Anderson DC, and Ward PA. Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91: 577-587, 1993.
42. Mulligan MS, Smith CW, Anderson DC, Todd RF III, Miyasaka M, Tamatani T, Issekutz TB, and Ward PA. Role of leukocyte adhesion molecules in complement-induced lung injury. J Immunol 150: 2401-2406, 1993.
43. Mulligan MS, Varani J, Warren JS, Till GO, Smith CW, Anderson DC, Todd RF III, and Ward PA. Roles of β2 integrins of rat neutrophils in complement-and oxygen radicalmediated acute inflammatory injury. J Immunol 148: 1847-1857, 1992.
44. Newman S, Glovsky MM, Ghekiere L, and Alenty A. Quantitative requirements for C3 to induce Forssman systemic shock and cutaneous hemorrhagic vasculitis in guinea pigs. J Allergy Clin Immunol 59: 327-333, 1977.
45. Ramos BF, Zhang Y, and Jakschik BA. Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. J Immunol 152: 1380-1384, 1994.
46. Regal JF. Role of the complement system in pulmonary disorders. Immunopharmacology 38: 17-25, 1997.
47. Rossi GL and Olivieri D. Does the mast cell still have a key role in asthma? Chest 112: 523-529, 1997.
48. Schellenberg RR and Foster A. In vitro responses of human asthmatic airway and pulmonary vascular smooth muscle. Int Arch Allergy Appl Immunol 75: 237-241, 1984.
49. Scherzer H and Ward PA. Lung injury produced by immune complexes of varying composition. J Immunol 121: 947-952, 1978.
50. Segal AM, Calabrese LH, Ahmad M, Tubbs RR, and White CS. The pulmonary manifestations of systemic lupus erythematosus. Semin Arthritis Rheum 14: 202-224, 1985.
51. Sjolander A, Schippert A, and Hammarstrom S. A human epithelial cell line, intestine 407, can produce 5-hydroxyeicosatetraenoic acid and leukotriene B4. Prostaglandins 45: 85-96, 1993.
52. Steinhilber D. 5-Lipoxygenase: a target for antiinflammatory drugs revisited. Curr Med Chem 6: 71-85, 1999.
53. Stephan V, Kuhr J, and Urbanek R. Anti-IgE-and complement-induced histamine release from peripheral leukocytes in normals and atopics. Int Arch Allergy Appl Immunol 90: 326-330, 1989.
54. Stimler NP, Bloor CM, and Hugli TE. C3a-induced contraction of guinea pig lung parenchyma: role of cyclooxygenase metabolites. Immunopharmacology 5: 251-257, 1983.
55. Stimler NP, Hugli TE, and Bloor CM. Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol 100: 327-338, 1980.
56. Strunk RC, Eidlen DM, and Mason RJ. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 81: 1419-1426, 1988.
57. Till GO, Johnson KJ, Kunkel R, and Ward PA. Intravascular activation of complement and acute lung injury; dependency on neutrophils and toxic oxygen metabolites. J Clin Invest 69: 1126-1135, 1982.
58. Tulunay M, Demiralp S, Tastan S, Akalin H, Ozyurda U, Corapcioglu T, and Akarsu ES. Complement (C3, C4) and C-reactive protein responses to cardiopulmonary bypass and protamine administration. Anaesth Intensive Care 21: 50-55, 1993.
59. Umetsu DT and DeKruyff RH. Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases. Proc Soc Exp Biol Med 215: 11-20, 1997.
60. Vogt W. Anaphylatoxins: possible roles in disease. Complement 3: 177-188, 1986.
61. Ward PA. Leukotaxis and leukotactic disorders. A review. Am J Pathol 77: 520-538, 1974.
62. Warren JS, Kunkel SL, Johnson KJ, and Ward PA. In vitro activation of rat neutrophils and alveolar macrophages with IgA and IgG immune complexes. Implications for immune complex-induced lung injury. Am J Pathol 129: 578-588, 1987.
63. Warren JS, Yabroff KR, Remick DG, Kunkel SL, Chensue SW, Kunkel RG, Johnson KJ, and Ward PA. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 84: 1873-1882, 1989.
64. Wasserman SI. Mast cells and airway inflammation in asthma. Am J Respir Crit Care Med 150: S39-S41, 1994.
65. Williams TJ, Hellewell PG, and Jose PJ. Inflammatory mechanisms in the Arthus reaction. Agents Actions 19: 66-72, 1986.
66. Williams TJ and Jose PJ. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med 153: 136-153, 1981.
67. Wollina U. Immune complexes - pathogenetic factors of autoimmune systemic lupus erythematosus. Allerg Immunol (Leipz) 30: 3-13, 1984.